Patton Fund Management Inc. has made a notable move by purchasing 10,132 shares of Moderna, Inc., valued at about $280,000. According to a recent SEC filing, this acquisition took place in the second quarter and aligns with similar investments by other hedge funds.
Subscribe
Biotechnology
Industry News
Stock Market
Patton Fund Management Inc. Buys Shares of 10,132 Moderna, Inc. $MRNA
Photo by Markets Daily
Key Takeaways:
- Patton Fund Management Inc. purchased 10,132 Moderna shares in Q2.
- The stake is valued at approximately $280,000.
- The purchase details were disclosed in an SEC filing.
- Moderna trades on the NASDAQ under the symbol MRNA.
- Other hedge funds have also increased their positions in Moderna.
Patton Fund Management’s Q2 Move
Patton Fund Management Inc. recently acquired a new stake in Moderna, Inc. (NASDAQ: MRNA – Free Report) during the second quarter. According to an official filing with the Securities and Exchange Commission, the fund bought 10,132 shares valued at an estimated $280,000.
Filing with the SEC
The details of this transaction were made available through the fund’s latest SEC disclosure. Such filings offer a transparent look at investment activities—essential information for both the market and potential investors.
A Wider Trend Among Hedge Funds
In addition to Patton Fund Management Inc.’s stake, a number of other hedge funds have also added shares of Moderna. While the filing references further investments, no specific details about these additional transactions were provided.
Moderna’s Market Ticker
Moderna, a prominent biotechnology company, is listed on the NASDAQ under the ticker symbol MRNA. Known for developing innovative treatments and vaccines, the company often attracts interest from institutional investors. These recent purchases bolster the ongoing attention the biotech sector has been receiving in financial circles.
